FORISH JOSEPH J 4
4 · HAEMONETICS CORP · Filed Jun 25, 2012
Insider Transaction Report
Form 4
FORISH JOSEPH J
VP, Human Resources
Transactions
- Exercise/Conversion
Common Stock
2012-06-21$48.20/sh+12,000$578,340→ 20,497 total - Sale
Common Stock
2012-06-21$71.14/sh−12,000$853,656→ 8,497 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-06-21$71.14/sh−12,000$853,656→ 0 totalExercise: $48.20From: 2006-12-19Exp: 2012-12-19→ Common Stock (12,000 underlying)
Holdings
- 10,373
Non-Qualified Stock Option (right to buy)
Exercise: $52.76From: 2007-05-05Exp: 2013-05-05→ Common Stock (10,373 underlying) - 11,799
Non-Qualified Stock Option (right to buy)
Exercise: $51.07From: 2008-10-24Exp: 2014-10-24→ Common Stock (11,799 underlying) - 14,690
Non-Qualified Stock Option (right to buy)
Exercise: $52.94From: 2010-10-27Exp: 2016-10-27→ Common Stock (14,690 underlying) - 15,388
Non-Qualified Stock Option (right to buy)
Exercise: $54.99From: 2011-10-27Exp: 2017-10-27→ Common Stock (15,388 underlying) - 11,911
Non-Qualified Stock Option (right to buy)
Exercise: $54.55From: 2009-10-22Exp: 2015-10-22→ Common Stock (11,911 underlying) - 15,370
Non-Qualified Stock Option (right to buy)
Exercise: $61.34From: 2012-10-25Exp: 2018-10-25→ Common Stock (15,370 underlying)
Footnotes (3)
- [F1]Pursuant to a 10b5-1 Plan.
- [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F3]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.